Crohn's Disease and Colitis Trial, Recruiting (NCT07077681)

Crohn's Disease and Colitis Trial, Recruiting NCT07077681 Sponsor: EG Labo Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT07077681 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have agreed to take part in the study and are happy for your health data to be used
You have moderate to severe Crohn's disease and are being treated with Stelara® using a pre-filled syringe, with injections every 8 or 12 weeks
You meet at least one of the following: a CRP blood test result below 5 mg/l, a stool calprotectin level below 250 μg/g, or a Harvey-Bradshaw symptom score below 5 (confirm with trial site if unsure which applies to you)
Your condition has been stable, meaning your Stelara® dose has not changed in the last 24 weeks and you have not needed steroid treatment for at least 3 months
Your doctor has already decided, with your agreement, to switch your treatment from Stelara® to a similar medicine called Uzpruvo®
You have access to the internet so you can complete online questionnaires

Who may not be able to join:

You are receiving Stelara® injections more frequently than every 8 weeks
You use a pre-filled pen device to take your Stelara® (rather than a pre-filled syringe)
You are currently taking part in another clinical trial that involves a medical intervention
You are unable or unwilling to follow the study procedures, such as being reachable by phone or completing online questionnaires
You are under a legal protection order, guardianship, or curatorship (confirm with trial site if unsure whether this applies to you)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07077681

Sponsor: EG Labo

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

More information: https://clinicaltrials.gov/study/NCT07077681

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have agreed to take part in the study and are happy for your health data to be used
You have moderate to severe Crohn's disease and are being treated with Stelara® using a pre-filled syringe, with injections every 8 or 12 weeks
You meet at least one of the following: a CRP blood test result below 5 mg/l, a stool calprotectin level below 250 μg/g, or a Harvey-Bradshaw symptom score below 5 (confirm with trial site if unsure which applies to you)
Your condition has been stable, meaning your Stelara® dose has not changed in the last 24 weeks and you have not needed steroid treatment for at least 3 months
Your doctor has already decided, with your agreement, to switch your treatment from Stelara® to a similar medicine called Uzpruvo®
You have access to the internet so you can complete online questionnaires

Who may not be able to join:

You are receiving Stelara® injections more frequently than every 8 weeks
You use a pre-filled pen device to take your Stelara® (rather than a pre-filled syringe)
You are currently taking part in another clinical trial that involves a medical intervention
You are unable or unwilling to follow the study procedures, such as being reachable by phone or completing online questionnaires
You are under a legal protection order, guardianship, or curatorship (confirm with trial site if unsure whether this applies to you)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

EG Labo

Registry

ClinicalTrials.gov

Start date

2 June 2025

Est. completion

30 April 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

maintenance of treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov